Board members

The Board of the Francis Crick Institute currently comprises eleven members. Click on the name of the Board member to find out more.

  1. Sir David Cooksey (Chairman)

    Sir David Cooksey chairs Bechtel Ltd, the engineering construction company. Until January 2012, he was Chairman of the Board of UK Financial Investments Limited, the company set up to manage the government's investments in the banks.

    Sir David Cooksey (Chair)

    After founding venture capital firm Advent Venture Partners in 1981, he went on to hold several senior positions in the private and public sectors including Chairman of the Audit Commission, 1986-1995, a Director of the Bank of England, 1994 - 2005, and a Governor of the Wellcome Trust.

    In 2006 Sir David was commissioned by the Government to carry out an independent review of arrangements for funding health research in the UK. The resulting report set out a vision for enhancing the effectiveness of medical research in the UK. It was a stimulus for the founding of the Francis Crick Institute.


  2. Professor Maggie Dallman

    Maggie Dallman is Principal of the Faculty of Natural Sciences at Imperial College London. She is also Professor of Immunology with an interest in understanding diseases involving excessive immunity and inflammation.

    Professor Maggie Dallman, Imperial College London

    Maggie sits on the boards of several research and health organisations including the Imperial College Healthcare NHS Trust Board; the Biotechnology and Biological Sciences Research Council (BBSRC) Strategy Advisory Board; the BBSRC Basic Sciences Underpinning Health Board (Chair); the Institute for Animal Health Scientific Advisory Board; the NC3Rs Board; and the HEFC Research and Innovation Strategic Advisory Committee.

    Maggie held a Medical Research Council Senior Research Fellowship at the University of Oxford before joining Imperial College in 1994. She held increasingly senior positions in the College and was appointed to her current role in 2008.

    More about Professor Maggie Dallman at Imperial College London


  3. Professor Dr Peter Gruss

    Peter Gruss' research career focused on transcription control in viruses and mammalian development. He co-discovered the transcriptional enhancer and identified regulators for e.g. insulin producing cells of the pancreas as well as the mammalian eye.

    During his scientific career he worked at the Institute for Virus Research Heidelberg (1977), the National Institutes of Health Bethesda (1978-1982) and the Institute for Microbiology, and was offered a professorship at the University of Heidelberg in 1982. In 1986, he was appointed Director of the Max Planck Institute for Biophysical Chemistry in Göttingen and Scientific Member of the Max Planck Society. He authored patents and co-founded two biotech companies.

    Under his leadership as President (2002-2014) the Max Planck Society not only expanded into new scientific fields as well as established new funding structures, but also developed into a truly international scientifically renowned organization.

    Peter is a member of the Supervisory Boards Munich RE, Actelion Pharmaceuticals and (until 1/2015) of Siemens AG as well as of the Advisory Board of Deloitte and chairs the Siemens' Technology and Innovation Council. He was a member of the "Innovation Dialogue" of the Federal Chancellery. Peter is also an elected member of the American Academy of Arts and Sciences.


  4. Dr Lynne Gailey

    Lynne Gailey currently sits on the University College London Hospitals (UCLH) Charitable Foundation Development Board giving strategic communications advice to the Chief Executive and tactical communications support to the fundraising team.

    Lynne Gailey, independent Board member and Trustee

    She was formerly Global Communications  Leader for GE Healthcare responsible for reputation and image. Previously Lynne spent more than three years as Director of Corporate Affairs at Amersham plc with responsibility for all aspects of communications including media relations, public affairs and internal communications. Lynne received a PhD in Chemistry and a degree in Chemistry from Leeds University.


  5. Sir Harpal Kumar

    Sir Harpal Kumar is Chief Executive of Cancer Research UK, appointed in 2007 following three years as Chief Operating Officer and five years as Chief Executive of Cancer Research Technology Limited, a wholly-owned subsidiary of Cancer Research UK.

    Harpal is also Chairman of the Beatson Institute for Cancer Research in Glasgow, a Trustee of the Institute for Cancer Research in London, and serves on the boards of the National Cancer Research Institute and the UK Clinical Research Collaboration. He co-chairs the National Awareness and Early Diagnosis Initiative and is Deputy Chair of the Advisory Board for the Cancer Reform Strategy in England.

    He was knighted in the 2016 New Years Honours List.

    More about Harpal Kumar at Cancer Research UK


  6. The Rt Hon Lord Willetts

    David Willetts is Executive Chair of the Resolution Foundation, a Visiting Professor at King's College London, Governor of the Ditchley Foundation, Chair of the British Science Association and a member of the Council of the Institute for Fiscal Studies.

    He was Minister for Universities and Science, attending Cabinet, from 2010-2014. He was the Member of Parliament for Havant from 1992-2015. Before that, David worked at HM Treasury and the Number 10 Policy Unit. He also served as Paymaster General in the last Conservative Government. In October 2015 David became a member of the House of Lords.

    David has written widely on economic and social policy. His most recent book 'The Pinch' was published by Atlantic Books in 2010.


  7. Professor David Lomas

    David Lomas is Vice Provost (Health), Head of UCL School of Life and Medical Sciences and Head of UCL Medical School.  He is the Academic Director of the UCLPartners Academic Health Science Centre and a member of the Board at UCLH.   David is an NIHR Senior Investigator and works as a respiratory physician at UCLH and the Royal Free Hospital.  He is Chair of the Population and Systems Medicines Board at the Medical Research Council and previously chaired the Respiratory Therapy Area Unit Board at GlaxoSmithKline.

    David received his medical degree from the University of Nottingham and undertook his PhD at Trinity College, Cambridge. He was an MRC Clinician Scientist, University Lecturer and Professor of Respiratory Biology in Cambridge before moving to UCL in 2013 to be Chair of Medicine and Dean of the Faculty of Medical Sciences. 


  8. Professor Sir Robert Lechler

    Robert Lechler is President of the Academy of Medical Sciences; Vice President (Health) and Professor of Immunology at King's College London; and Executive Director of King's Health Partners Academic Health Sciences Centre.

    Professor Sir Robert Lechler

    Robert's research interests revolve around transplantation tolerance. The central aim of his research is to persuade the immune system to "tolerate" the foreign organ while retaining full capability to fight off infections and cancer.

    More about Professor Sir Robert Lechler at King's College London


  9. Philip Yea

    Philip is Chairman of Greene King plc, and is also a non-executive director of Vodafone Group plc, Computacenter plc and Aberdeen Asian Smaller Companies Investment Trust plc. He chaired the board of trustees of the British Heart Foundation from 2009 to 2015.

    Philip Yea

    He was Chief Executive of the private equity group 3i between 2004 and 2009 and, before then, was a partner in the private equity business of Investcorp, focusing on the performance of portfolio investments. He is a former Finance Director of Diageo, the leading drinks group. A member of the Chartered Institute of Management Accountants, Philip chairs the Crick's audit committee. 


  10. Jeremy Farrar

    Jeremy Farrar is Director of the Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in health by supporting the brightest minds. Before joining the Trust he was Director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were in infectious diseases, tropical health and emerging infections. He has contributed to 500 peer-reviewed scientific papers, and served on several World Health Organization advisory committees.

    Jeremy Farrar

    Jeremy was appointed OBE in 2005 for services to Tropical Medicine, and he has been awarded the Memorial Medal and Ho Chi Minh City Medal from the Government of Vietnam, Frederick Murgatroyd Prize for Tropical Medicine by the Royal College of Physicians and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a Fellow of the Academy of Medical Sciences, and chairs the International Severe Acute Respiratory and Emerging Infection Consortium, a global initiative to share data about emerging diseases that could become epidemics or pandemics.


  11. Professor Doreen Cantrell

    Professor Doreen Cantrell is a Wellcome Trust Principal Research Fellow, Head of the College of Life Sciences and Vice Principal of the University of Dundee.  From 1987 to 2002 she was Head of the Lymphocyte Activation Laboratory at the Cancer Research UK London Research Institute.

    Doreen was elected a Fellow of the Academy of Medical Sciences and EMBO in 2000, a Fellow of the Royal Society of Edinburgh in 2005, a Fellow of the Royal Society in 2011 and was awarded Commander of the British Empire in the 2014 New Year Honours.  She has sat on numerous scientific committees and editorial boards and is currently a Member of the Medical Research Council, Member of the Babraham Institute Board, Trustee of the Royal Society of Edinburgh Council and Member of the Sir Henry Dale Fellowship Interview Committee.

    More about Professor Doreen Cantrell at University of Dundee, College of Life Sciences: